Literature DB >> 4434121

Blood and neoplastic diseases. Myelomatosis.

J S Malpas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4434121      PMCID: PMC1612623          DOI: 10.1136/bmj.4.5943.520

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

Review 1.  Diagnosis and treatment of hypercalcaemia.

Authors:  L Watson
Journal:  Br Med J       Date:  1972-04-15

2.  Ineffectiveness of fluoride therapy in multiple myeloma.

Authors:  J B Harley; A Schilling; O Glidewell
Journal:  N Engl J Med       Date:  1972-06-15       Impact factor: 91.245

3.  Bone healing in multiple myeloma with melphalan chemotherapy.

Authors:  L H Rodriguez; J B Finkelstein; C C Shullenberger; R Alexanian
Journal:  Ann Intern Med       Date:  1972-04       Impact factor: 25.391

4.  Combination chemotherapy for multiple myeloma.

Authors:  R Alexanian; J Bonnet; E Gehan; A Haut; J Hewlett; M Lane; R Monto; H Wilson
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

5.  Fluoride effect on bone in plasma cell myeloma.

Authors:  P P Carbone; I Zipkin; L Sokoloff; P Frazier; P Cook; F Mullins
Journal:  Arch Intern Med       Date:  1968-02

6.  Modes of escape from therapeutic control in myelomatosis.

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1971-05-08

7.  Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.

Authors:  D E Bergsagel; D H Cowan; R Hasselback
Journal:  Can Med Assoc J       Date:  1972-11-04       Impact factor: 8.262

8.  Kinetics of tumor growth and regression in IgG multiple myeloma.

Authors:  P W Sullivan; S E Salmon
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

  8 in total
  1 in total

Review 1.  Achievements of cancer chemotherapy.

Authors:  J S Tobias; J M Whitehouse
Journal:  J R Coll Physicians Lond       Date:  1976-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.